Bliss GVS Pharma Limited (BLISSGVS) — Board Meeting | 12 August 2026

12 August 2026 · NSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Board approved unaudited Q1 results and director appointment

🔄 What Changed

Net profit rose to ₹3,861.77 lakhs from ₹3,242.25 lakhs in prior quarter; revenue increased to ₹23,034.67 lakhs

💡 Investor Takeaway

The company disclosed strong quarterly profit growth and a new director appointment, signaling operational progress and governance updates.

The Board of Bliss GVS Pharma approved unaudited standalone and consolidated financial results for Q1 June 2026, showing revenue of ₹23,034.67 lakhs and net profit of ₹3,861.77 lakhs. It also approved the appointment of Mr. Santosh Parab as a Non-Executive Non-Independent Director via postal ballot. The meeting ran from 4:22 p.m. to 6:15 p.m. on August 12, 2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — BLISSGVS ✨ Ask AI About This

About Bliss GVS Pharma Limited (BLISSGVS)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹7,530.52 CrP/E: 55.1ROE: 11.4%ROCE: 17.5%Div Yield: 0.14%

View full BLISSGVS stock details →

📡 Get AI alerts when BLISSGVS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BLISSGVS — Free

💡 Ask AI about this filing

"How does Q1 profit growth compare to peers?""What is the impact of the new director on strategy?""When will full audited results be released?"

Ask AI Free →

📊 More BLISSGVS filings

Announcement — 29 September 2026Bliss GVS Pharma announced that its trading window closes on October 1, 2026, ahead of unaudited qua...
🟡 Board Meeting — 28 September 2026Bliss GVS Pharma announced on September 28, 2026 that Anupam Rasayan India Limited, via its subsidia...
🟡 Board Meeting — 28 September 2026Bliss GVS Pharma announced a board meeting on October 1, 2026, to consider establishing two employee...
🟡 Board Meeting — 28 September 2026Bliss GVS Pharma announced the completion of Anupam Rasayan India's acquisition of 47.95% stake, mak...
🟡 Board Meeting — 28 September 2026Bliss GVS Pharma announced that its board approved the reclassification of 22 outgoing promoters fro...

See all BLISSGVS filings →

🔥 Also filed on 12 August 2026

DBLDilip Buildcon LimitedCorporate Action NITCONitco LimitedFinancial Results KPIGREENKPI Green Energy LimitedFinancial Results SDBLSom Distilleries & Breweries LimitedFinancial Results CONSOFINVTConsolidated Finvest & Holdings LimitedCorporate Action TOUCHWOODTouchwood Entertainment LimitedFinancial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BLISSGVS files new disclosures

Track BLISSGVS filings, board meetings, and corporate actions. Free email alerts at 5 PM.